Beyond the numbers: Explore the trends and ideas shaping Australian business. Listen now.
Sukvinder has been advising in Research & Development (R&D) for over 20 years. Central to her approach is understanding your business and your needs related to the identification, preparation and support of your R&D claim. This includes timeliness of R&D tax compliance work whether you are a small company or large and supporting you through all phases of an ATO or AusIndustry review.
How Australian biotech can use funding, clinical research and global markets to drive growth.
Australia’s R&D policy is back in focus ahead of the Federal Budget, with the SERD review highlighting declining investment and the need for reform. While no immediate changes to the R&D Tax Incentive have been announced, businesses should watch for potential policy shifts and ensure strong governance, compliance, and documentation under the current framework.
Built on world-class research and clinical trials, Australia’s biotech industry is increasingly shifting towards commercialisation, global expansion, and long-term growth.
